United States · FDA National Drug Code directory
Ticagrelor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-993_555d4e44-9bb2-474e-9bea-c549e3261dbb
- Product NDC
- 42385-993
- Form
- TABLET
- Composition / generic term
- Ticagrelor
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260820
- Source listing expiry
- 20271231
Source-listed ingredients
- TICAGRELOR — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (42385-993-01) · 42385-993-01
- 500 TABLET in 1 BOTTLE (42385-993-05) · 42385-993-05
- 1000 TABLET in 1 BOTTLE (42385-993-11) · 42385-993-11
- 30 TABLET in 1 BOTTLE (42385-993-30) · 42385-993-30
- 60 TABLET in 1 BOTTLE (42385-993-60) · 42385-993-60
- 10 BLISTER PACK in 1 CARTON (42385-993-68) / 10 TABLET in 1 BLISTER PACK (42385-993-10) · 42385-993-68
- 10 BLISTER PACK in 1 CARTON (42385-993-72) / 10 TABLET in 1 BLISTER PACK (42385-993-17) · 42385-993-72
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →